Urology Conferences

Low-PSA, High-Grade Prostate Cancer Especially Lethal

Low-PSA, High-Grade Prostate Cancer Especially Lethal

By

Men with PSA values of 2.5 ng/mL or less and Gleason 8 to 10 prostate tumors are at higher risk of death than other high-risk PCa patients.

Worse Survival After Robotic Cystectomy Seen at Low-Volume Centers

Worse Survival After Robotic Cystectomy Seen at Low-Volume Centers

By

The researchers found lower overall survival among patients undergoing robot-assisted radical cystectomy at hospitals performing 10 or fewer procedures during 2010 to 2012.

MRI Accuracy for Prostate Cancer Challenged

MRI Accuracy for Prostate Cancer Challenged

By

Systematic biopsies always should be performed in conjunction with targeted biopsy in men with suspected clinically significant PCa at mpMRI.

Novel PSA Assay Improves Prostate Cancer Diagnosis

Novel PSA Assay Improves Prostate Cancer Diagnosis

By

The new test, IsoPSA, measures all PSA isoforms in serum and more accurately discriminates high-grade cancer from benign disease.

Pure Bladder Cancer Variants Linked to Worse Survival After RC

Pure Bladder Cancer Variants Linked to Worse Survival After RC

By

Patients with a pure variant had significantly lower survival odds than those with pure urothelial carcinoma over a median 6.5 years of follow up.

Real-World mUCB Patient Survival Worse Than in Clinical Trials

Real-World mUCB Patient Survival Worse Than in Clinical Trials

By

Just 1 in 4 patients diagnosed with metastatic urothelial carcinoma of the bladder survive for a year, according to US national registry data.

Robot-assisted Radical Cystectomy on the Rise

Robot-assisted Radical Cystectomy on the Rise

By

By 2014 to 2015, 1 in 3 bladder cancer surgical procedures performed in the United States were robot-assisted.

Neoadjuvant Chemo Benefits Some Variant MIBC Patients

Neoadjuvant Chemo Benefits Some Variant MIBC Patients

By

Researchers find prolonged survival among patients with neuroendocrine muscle-invasive bladder cancer.

Post-chemo PD-L1 Tied to Worse Prognosis in Bladder Cancer Pts

Post-chemo PD-L1 Tied to Worse Prognosis in Bladder Cancer Pts

By

Five-year cancer-specific survival rates were 48.1% and 69.6% for PD-L1 positive and negative patients, respectively.

AUA Releases Updated Renal Mass Guidelines

AUA Releases Updated Renal Mass Guidelines

By

The document spells out in greater detail the criteria for radical and partial nephrectomy and for placing patients on active surveillance.

Imaging Technique Improves Bladder Tumor Surveillance

By

Daneshmand: Blue flexible cystoscopy used in an office-setting can improve detection of bladder cancer recurrence.

PCa Active Surveillance Safe, Effective for Younger Patients

PCa Active Surveillance Safe, Effective for Younger Patients

By

A majority of active surveillance patients under age 60 did not progress to definitive prostate cancer treatment.

MRI-Fusion Biopsy Benefits PCa Active Surveillance Patients

MRI-Fusion Biopsy Benefits PCa Active Surveillance Patients

By

Targeting PI-RADS 4 and 5 lesions for confirmatory biopsy improves detection of clinically significant cancer.

Sipuleucel-T Survival Benefit Greater in Blacks

Sipuleucel-T Survival Benefit Greater in Blacks

By

Median overall survival was 9.3 months longer for black versus white patients with metastatic castration-resistant prostate cancer.

Low Testosterone Increases Women's Urinary Incontinence Risk

Low Testosterone Increases Women's Urinary Incontinence Risk

By

Lowest quartile of serum testosterone is associated with 48% and 65% increased odds of stress and mixed urinary incontinence, respectively.

Fusion Biopsy Ups Detection of Clinically Significant PCa

Fusion Biopsy Ups Detection of Clinically Significant PCa

By

Fusion biopsy has improved over the last decade and increasingly detects clinically significant prostate cancer, according to data trends from one institution.

Prostate Photovaporization for BPH Beneficial Long-Term

Prostate Photovaporization for BPH Beneficial Long-Term

By

Average International Prostate Symptom Score remained low 5 years after the PVP laser procedure.

New-Onset Urinary Incontinence Common After HoLEP for BPH

New-Onset Urinary Incontinence Common After HoLEP for BPH

By

Researchers identified a predictor of new-onset UI after HoLEP that may aid urologists in clinical practice.

Water Vapor Ablation Eases BPH-Related Urinary Retention

Water Vapor Ablation Eases BPH-Related Urinary Retention

By

In a study, 81.1% of men were able to void after an average of 28 days after treatment.

Prostate Cancer Distant Metastasis Predicted by APV

Prostate Cancer Distant Metastasis Predicted by APV

By

Highest quartile of alkaline phosphatase velocity in men who experience biochemical recurrence after radical prostatectomy is associated with 2-fold higher risk.

Non-index Lesions at Biopsy Help Predict Adverse RP Outcomes

Non-index Lesions at Biopsy Help Predict Adverse RP Outcomes

By

Systematic biopsy parameters identified patients at higher risk of positive surgical margins.

Bladder Cancer Survival Worse Among Women Despite RC

Bladder Cancer Survival Worse Among Women Despite RC

By

Among stage 2 to 4 bladder cancer patients, women had lower cancer-specific survival than men.

HoLEP Feasible for BPH Patients With Low-risk Prostate Cancer

HoLEP Feasible for BPH Patients With Low-risk Prostate Cancer

By

The laser procedure was successful for 7 selected patients with enlarged prostates and LUTS harboring low-risk prostate cancer.

Variant Histology Predicts Worse Bladder Cancer Outcomes

Variant Histology Predicts Worse Bladder Cancer Outcomes

By

Study finds a higher death risk following radical cystectomy for squamous cell and small cell carcinoma and micropapillary histologic subtypes.

VTE Risk Continues Long After Bladder Cancer Surgery

VTE Risk Continues Long After Bladder Cancer Surgery

By

The cumulative incidence of venous thromboembolism following radical cystectomy was nearly 6.7% over 10 years.

Early CRP Response to mRCC Drugs Predicts Survival

Early CRP Response to mRCC Drugs Predicts Survival

By

Changes in C-reactive protein levels 4 weeks after starting sunitinib or sorafenib treatment are associated with overall and progression-free survival.

Post-Cystectomy Deaths Among HD Patients Seldom Due to Cancer

Post-Cystectomy Deaths Among HD Patients Seldom Due to Cancer

By

Following radical cystectomy for bladder cancer, end-stage renal disease patients are 3-4 times more likely to die from causes other than cancer.

Continent Diversion After Bladder Cancer Surgery on the Decline

Continent Diversion After Bladder Cancer Surgery on the Decline

By

Use of continent diversion procedures peaked in 2008, and has been decreasing since.

Diabetes Increases Penile Prosthesis Infection Risk

Diabetes Increases Penile Prosthesis Infection Risk

By

Diabetic men receiving an inflatable penile prosthesis have a 69% increased risk of device-associated infection compared with non-diabetics.

Bladder Cancer Patient Smoking Intensity Influences Survival

Bladder Cancer Patient Smoking Intensity Influences Survival

By

Patients smoking 1 or more packs of cigarettes per day had a higher risk of death compared with those who smoked less than 1.

Sign Up for Free e-newsletters